According to the Legislative Budget Board (LBB), HB 1787 is not expected to have a significant fiscal impact on the state. The bill mandates the Department of State Health Services (DSHS) and the Texas Higher Education Coordinating Board (THECB) to jointly develop a human papillomavirus (HPV) education and prevention plan, specifically targeting students at institutions of higher education. However, the legislation stipulates that this work should be conducted using existing agency resources and programs, thereby avoiding the need for new appropriations.
The fiscal analysis concludes that both DSHS and THECB can absorb any implementation costs within their current budgetary frameworks. There are no mandates for new programs requiring ongoing or large-scale operational funding, and the informational materials, public outreach, and planning efforts proposed in the bill are designed to be integrated into pre-existing infrastructure.
At the local level, the bill also poses no significant fiscal implications for municipalities, counties, or school districts. The implementation focuses on state-level coordination and online resources, minimizing administrative or compliance burdens on local entities.
While HB 1787 is framed as a low-cost, voluntary public health initiative, it nonetheless raises substantive concerns about the proper role of government in higher education and health-related outreach. The bill directs the Department of State Health Services (DSHS) and the Texas Higher Education Coordinating Board (THECB) to develop and administer a state plan for HPV prevention and education across all public institutions of higher education. Even though the bill specifies that existing resources are to be used, the creation of a new state plan, recurring agency coordination, and potential impact studies represent an expansion of state activity into an area previously left to parental, personal, and private sector discretion.
This formal expansion, though procedurally modest, sets a precedent that could invite future legislative or budgetary proposals to grow the program. Once codified in statute, new responsibilities within agencies often evolve in scope over time, leading to incremental government growth that is difficult to reverse. Lawmakers concerned with keeping state functions lean and tightly bounded may view HB 1787 as unnecessary mission creep.
Additionally, the subject matter—human papillomavirus, a sexually transmitted infection—raises legitimate cultural and ethical considerations. The bill implicitly encourages “catch-up” vaccination up to age 26, including among young adults who may still be influenced by family values and religious perspectives that prefer such medical decisions remain private and parent-guided. Although the program is not mandatory, using state-run institutions to promote HPV vaccination and awareness may be seen as government overreach into moral and medical issues that should be decided by individuals and families without state encouragement.
The timing and context of this bill also matter. In the wake of significant public distrust in government-led health initiatives following the COVID-19 pandemic, constituents and lawmakers alike are rightfully wary of policies that could be perceived as soft mandates or vaccine advocacy in public institutions. HB 1787, by establishing official state programs and education campaigns around HPV, may unintentionally normalize state-sanctioned health messaging in ways that could later be expanded to more controversial or coercive ends.
For these reasons—concerns about incremental expansion of state authority, intrusion into sensitive cultural and medical areas, and broader implications for the role of public health messaging in government institutions—Texas Policy Research recommends that lawmakers vote NO on HB 1787. It is a policy solution looking for a problem better addressed by families, physicians, and private healthcare providers, not by the state. Texas Policy Research recommends that lawmakers vote NO on HB 1787.